超声微泡载药策略提升小鼠原位膀胱癌吉西他滨摄取的评价
研究在小鼠原位肌层浸润性膀胱癌模型及RT112细胞系中比较三种微泡载吉西他滨策略:共给药、微泡-脂质体偶联及微泡表面直接载药。体外与体内超声暴露均未显著提高共给药组药物摄取;体内仅微泡表面直接载药组显著增加肿瘤cleaved caspase 3表达,提示吉西他滨诱导的凋亡。
要点
- 共给药吉西他滨与微泡联合超声未显著提高体外或体内药物摄取。
- 微泡-脂质体偶联可延长吉西他滨血浆循环时间但未显著增加肿瘤凋亡。
- 仅微泡表面直接载药组肿瘤cleaved caspase 3表达显著增加。
诊断标准与关键数值
- 体外超声条件:1 MHz中心频率、0.07 MPa峰值负压、3000 cycles、100 Hz脉冲重复频率。
- 体内超声条件:1.1 MHz中心频率、1.0 MPa峰值负压、20000 cycles、0.5 Hz脉冲重复频率。
- 共给药Gem+MB组体外与体内药物摄取较药物对照均无显著增加。
- 体内GemlipoMB延长吉西他滨血浆循环时间,但仅GembioMB显著增加肿瘤cleaved caspase 3表达。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In this study we compared three different microbubble-based approaches to the delivery of a widely used chemotherapy drug, gemcitabine: (i) co-administration of gemcitabine and microbubbles (Gem+MB); (ii) conjugates of microbubbles and gemcitabine-loaded liposomes (GemlipoMB); and (iii) microbubbles with gemcitabine directly bound to their surfaces (GembioMB). Both in vitro and in vivo investigations were carried out, respectively, in the RT112 bladder cancer cell line and in a murine orthotopic muscle-invasive bladder cancer model. The in vitro (in vivo) ultrasound exposure conditions were a 1 (1.1) MHz centre frequency, 0.07 (1.0) MPa peak negative pressure, 3000 (20,000) cycles and 100 (0.5) Hz pulse repetition frequency. Ultrasound exposure produced no significant increase in drug uptake either in vitro or in vivo compared with the drug-only control for co-administered gemcitabine and microbubbles. In vivo, GemlipoMB prolonged the plasma circulation time of gemcitabine, but only GembioMB produced a statistically significant increase in cleaved caspase 3 expression in the tumor, indicative of gemcitabine-induced apoptosis.
引用
- Ruan JL, Browning RJ, Yildiz YO, et al. Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles. Ultrasound Med Biol. 2021. PMID: 33707089. doi:10.1016/j.ultrasmedbio.2021.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。